dC (Bz) (5-Me) CPG
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyuridine base into the 3' end of an oligonucleotide.
CPG used to incorporate a deoxyinosine base into the 3' end of an oligonucleotide.
CPG for incorporation of a C2 spacer at the 3' end of an oligonucleotide.
CPG for incorporation of cholesterol at 3' end of an oligonucleotide, with a dR spacer
CPG used to incorporate a bromo-modified uridine at the 3' end of an oligonucleotide.
CPG for 3' phosphate modification of an oligonucleotide.
CPG for incorporation of GalNAc at 3' end of an oligonucleotide, with a dR spacer
CPG used to incorporate a BlackBerry-650™ moiety at the 3' end of an oligonucleotide.
CPG for the incorporation of an amino function at the 3' end of an oligonucleotide.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 5304 2200 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 5304 2200 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |